Empacrux-L 25/5 Tablets are a combination antidiabetic medication containing Empagliflozin and Linagliptin, used in the treatment of Type-2 diabetes mellitus.
Empagliflozin belongs to the SGLT2 inhibitor class that helps remove excess glucose through urine, while Linagliptin is a DPP-4 inhibitor that helps increase insulin release and decrease glucagon levels after meals.
Together, these medicines help improve blood sugar control, reduce the risk of complications associated with diabetes, and support better overall glucose management when used along with diet and exercise.
This medicine should be taken only under medical supervision.
Key Benefits
Helps control blood sugar levels
Effective combination therapy for Type-2 diabetes
Supports improved glycemic control
Helps reduce excess glucose through urine
Convenient tablet dosage form
Directions for Use
Take the tablet exactly as prescribed by your doctor
Usually taken once daily with or without food
Swallow the tablet whole with water
Do not crush or chew the tablet
Safety & Precautions
For prescription use only
Not recommended for Type-1 diabetes
Consult doctor before use during pregnancy or breastfeeding
Monitor blood sugar regularly
Seek medical help if unusual symptoms occur
Storage
Store below 25°C
Keep in a cool and dry place
Protect from direct sunlight
Keep out of reach of children
Reviews
There are no reviews yet.